YU61893A - Modifikovani faktor-4 krvnih pločica - Google Patents

Modifikovani faktor-4 krvnih pločica

Info

Publication number
YU61893A
YU61893A YU61893A YU61893A YU61893A YU 61893 A YU61893 A YU 61893A YU 61893 A YU61893 A YU 61893A YU 61893 A YU61893 A YU 61893A YU 61893 A YU61893 A YU 61893A
Authority
YU
Yugoslavia
Prior art keywords
mpf
platelet factor
cpf
tiles
blood
Prior art date
Application number
YU61893A
Other languages
English (en)
Inventor
K.S. Gupta
P.J. Singh
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of YU61893A publication Critical patent/YU61893A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)

Abstract

MODIFIKOVANI FAKTOR-4 KRVNIH PLOČICA, ovaj pronalazak odnosi se na novi protein krvnih pločica faktor-4 obradjen u N-terminirajućoj oblasti (MPF-4), kao i proteolitički razdvojen neredukovan oblik faktora-4 krvnih pločica (CPF-4) koji ima primenu u inhibiciji angiogeneze. Pronlazak uključuje sastav MPF-4 i CPF-4 i postupke pripremanja MPF-4 i CPF-4 izdvajanjem iz kulture i rekombinantnom DNA.
YU61893A 1992-09-25 1993-09-24 Modifikovani faktor-4 krvnih pločica YU61893A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95279792A 1992-09-25 1992-09-25

Publications (1)

Publication Number Publication Date
YU61893A true YU61893A (sh) 1996-02-19

Family

ID=25493243

Family Applications (1)

Application Number Title Priority Date Filing Date
YU61893A YU61893A (sh) 1992-09-25 1993-09-24 Modifikovani faktor-4 krvnih pločica

Country Status (24)

Country Link
US (3) US5512550A (sh)
EP (1) EP0589719B1 (sh)
JP (1) JPH06220091A (sh)
KR (1) KR940007059A (sh)
CN (1) CN1035257C (sh)
AT (1) ATE151777T1 (sh)
AU (1) AU665114B2 (sh)
BR (1) BR9303903A (sh)
CA (1) CA2106629A1 (sh)
CZ (1) CZ195193A3 (sh)
DE (1) DE69309827T2 (sh)
DK (1) DK0589719T3 (sh)
ES (1) ES2101237T3 (sh)
FI (1) FI934183A (sh)
GR (1) GR3023356T3 (sh)
HK (1) HK100597A (sh)
HU (1) HUT69928A (sh)
IL (1) IL107040A0 (sh)
MX (1) MX9305901A (sh)
MY (1) MY109158A (sh)
NO (1) NO933423L (sh)
NZ (1) NZ248724A (sh)
YU (1) YU61893A (sh)
ZA (1) ZA936925B (sh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ195193A3 (en) * 1992-09-25 1994-04-13 Lilly Co Eli Modified factor-4 of blood platelets, process of its preparation and pharmaceutical preparation in which it is comprised
IL113561A0 (en) * 1994-05-09 1995-08-31 Lilly Co Eli Expression of recombinant mpf-4, cpf-4, pf-4 and precursor compounds
US5994292A (en) * 1995-05-31 1999-11-30 The United States Of America As Represented By The Department Of Health And Human Services Interferon-inducible protein 10 is a potent inhibitor of angiogenesis
JPH09143199A (ja) * 1995-11-17 1997-06-03 Nippon Chem Res Kk 血小板第４因子の製造方法
CN100389126C (zh) * 1995-12-13 2008-05-21 儿童医学中心公司 内皮细胞增殖抑制剂及其应用方法
FR2774990B1 (fr) * 1998-02-16 2000-07-28 Inst Vaisseaux Et Du Sang Nouveaux peptides, utilisation en therapeutique et compositions pharmaceutiques les renfermant
MXPA04002217A (es) 2001-09-12 2004-07-08 Sigma Tau Ind Farmaceuti Derivados de glucosaminoglucanas parcialmente desulfatados como inhibidores de heparanasa, dotados con actividad antiangiogenica y libres de efectos anticoagulantes.
US20090011981A1 (en) * 2004-09-15 2009-01-08 K.U. Leuven Research & Development Novel Inhibitors of Angiogenesis
CN114805536B (zh) * 2022-06-24 2022-09-02 北京百臻生物技术有限公司 一种人血小板因子4蛋白突变体及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737580A (en) * 1985-03-15 1988-04-12 Oncogen Platelet related growth regulator
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
US4844895A (en) * 1985-11-01 1989-07-04 New York University Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
AU1539188A (en) * 1987-05-04 1988-11-10 Bristol-Myers Squibb Company TGF-B2 and novel compositions having anti-neoplastic activity
US5086164A (en) * 1989-01-10 1992-02-04 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
US5187075A (en) * 1989-01-26 1993-02-16 Sri International Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses
US5112946A (en) * 1989-07-06 1992-05-12 Repligen Corporation Modified pf4 compositions and methods of use
EP0423641A3 (en) * 1989-10-18 1992-01-15 Nippon Mining Company Limited Expression vector, transformed microorganism, fusion protein and method for the production of platelet factor 4 or tgfalpha
WO1992002240A2 (en) * 1990-07-27 1992-02-20 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
CZ195193A3 (en) * 1992-09-25 1994-04-13 Lilly Co Eli Modified factor-4 of blood platelets, process of its preparation and pharmaceutical preparation in which it is comprised

Also Published As

Publication number Publication date
DE69309827D1 (de) 1997-05-22
ZA936925B (en) 1995-03-20
NZ248724A (en) 1995-10-26
EP0589719A1 (en) 1994-03-30
AU665114B2 (en) 1995-12-14
HU9302687D0 (en) 1993-12-28
FI934183A (fi) 1994-03-26
EP0589719B1 (en) 1997-04-16
NO933423L (no) 1994-03-28
DE69309827T2 (de) 1997-08-28
CA2106629A1 (en) 1994-03-26
US5935928A (en) 1999-08-10
HUT69928A (en) 1995-09-28
CN1088216A (zh) 1994-06-22
IL107040A0 (en) 1993-12-28
US5538949A (en) 1996-07-23
GR3023356T3 (en) 1997-08-29
NO933423D0 (no) 1993-09-24
MY109158A (en) 1996-12-31
JPH06220091A (ja) 1994-08-09
CZ195193A3 (en) 1994-04-13
MX9305901A (es) 1994-05-31
HK100597A (en) 1997-08-08
CN1035257C (zh) 1997-06-25
ATE151777T1 (de) 1997-05-15
BR9303903A (pt) 1994-06-14
KR940007059A (ko) 1994-04-26
DK0589719T3 (da) 1997-09-08
US5512550A (en) 1996-04-30
FI934183A0 (fi) 1993-09-24
ES2101237T3 (es) 1997-07-01
AU4757393A (en) 1994-03-31

Similar Documents

Publication Publication Date Title
DE3876401D1 (de) N-terminale fragmente von menschlichem serumalbumin.
ATE166387T1 (de) Adhäsionsvarianten
ATE110782T1 (de) Rekombinanter menschlicher endothelzellenwachstumsfaktor.
YU61893A (sh) Modifikovani faktor-4 krvnih pločica
DK0446315T3 (da) Fremgangsmåde til fremstilling af PAI-2
ES2058479T3 (es) Compuestos peptidicos.
ATE216706T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
DE58909261D1 (de) Ancrod-proteine, ihre herstellung und verwendung.
RU93054511A (ru) Тромбоцитарные факторы, фармацевтическая композиция, способ получения тромбоцитарных факторов, днк, вектор, клетка
ATE335817T1 (de) Adhäsionsvarianten